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ABStrAct
In this study we set out to determine the prevalence of depression and anxiety disorders among HIV 
infected persons, prevalence of substance use among these patients, effect of active and inactive use 
of substance on drug compliance and clinic attendance, and psychosocial correlates of substance 
use among these patients. This cross sectional study was conducted among patients who had been 
diagnosed with HIV disease in a teaching hospital in Sokoto, Nigeria. A questionnaire relating to 
socio-demographic variables, substance use and psychiatric morbidity was administered to the pa-
tients. Information obtained were analyzed using SPSS version 11 with the test of significance set at 
p<0.05. Our study showed that more male patients used substance than the female patients. In addi-
tion, the presence of psychiatric morbidity and substance use had implications for clinic attendance 
and drug compliance. In the overall management of HIV infected patients, regular screening for 
substance use and psychiatric morbidity should be carried out and referrals made appropriately. 
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introDuction
There is no gainsaying that HIV infection 
has assumed a pandemic nature the world 
over. In addition to its contribution to morbid-
ity and mortality, possible relationship of out-
come of treatment with psychiatric morbidity 
and substance use presents another dimension 
to the disease. In one study, about 50% of pa-
tients with HIV infection had substance use 
problems; 18.5% were frequent users of alco-
hol while half of the patients had psychiatric 
morbidity (Bing et al., 2001). Earlier studies 
however reported a smaller percentage (Maj 
et al., 1994; Ferrando, Evans, Goggin, Sewell, 
Fishman, & Rabkin 1998). In yet other stud-
ies prevalence of 22% to 32% (Evans, Fer-
rando, Sewell, Goggin, Fishman, & Rabkin, 
1998; Rabkin, Goetz, Remien, Williams, To-
dak, & Gorman, 1997) was reported which 
is 2 to 3 times higher than the prevalence of 
psychiatric disorders in the general commu-
nity population (Blazer, Kessler, McGonagle, 
& Swartz, 1994). A lower prevalence of 9% 
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of major depression and 2% of anxiety dis-
order were reported among the patients after 
6-months follow up (Perkins, Stern, Golden, 
Murphy, Naftolowitz, & Evans 1994.). It was 
observed that while depression had substantial 
impact on quality of life, anxiety has negative 
impact on social role and mental functioning. 
In addition, where substance use problem is 
present but not treated, there is non-adherence 
to antiretroviral drugs (Ironson et al., 2005). 
The overall consequence of substance use and 
psychiatric morbidity among patients with 
HIV infection is poor physical health, rapid 
progression to AIDS and death, particularly 
non AIDS related death (Ironson et al., 2005). 
In addition, Ironson et al. (2005) reported that 
psychosocial factors contribute significantly to 
the variance in disease progression.
Most studies on the prevalence of psychi-
atric morbidity and substance use are mainly 
from western society. In south western Ni-
geria, Adewuya et al. (2007) reported that the 
prevalence of depression was 59.1%. To our 
knowledge there is no study in the North west-
ern Nigeria which reports on the prevalence 
of psychiatric morbidity and substance use 
among such patients. This study is therefore 
aimed at investigating the prevalence of psy-
chiatric morbidity and substance use among 
patients with HIV infection in Sokoto. In ad-
dition, it seeks to determine the risk factors for 
the prevalence. 
In this study we sought to provide answers 
for the following questions: 1. What is the 
prevalence of psychiatric morbidity and sub-
stance use among patients with HIV infec-
tion in Sokoto? What variables are associated 
with psychiatric morbidity and substance use 
among the patients? 
MethoD
Study design and location 
This cross sectional study was carried out 
among patients who were diagnosed with HIV 
infection at the VCT (voluntary counseling 
and testing) centre of Usmanu Danfodiyo Uni-
versity Teaching Hospital (UDUTH), Sokoto, 
North-Western Nigeria. The study included 
167 consecutive adult patients who were at-
tending their routine clinic. Both symptomatic 
and non symptomatic patients were included. 
Ethical clearance was obtained from the hos-
pital to carry out the study. In addition, the 
consent of individual patients was obtained. 
Exclusion criteria were refusal to participate in 
the study, patients with cognitive impairment 
or positive history of debilitating or overt psy-
chiatric illness.
Variables relating to socio-demographic 
profile and substance use were collected by 
resident doctor in the department of com-
munity Health. The questionnaire to extract 
socio-demographic information and assess 
substance use was designed by one of the au-
thors. Psychosocial factors that were assessed 
in relation to substance use and psychiatric 
morbidity include marital status and educa-
tional attainment. Educational attainment was 
defined as the maximum education acquired 
by the individual patients, which in Nigeria 
education system include Primary, second-
ary and the tertiary (University, Polytechnic, 
Technical school and so on). The CAGE ques-
tionnaire was used to assess the harmful use 
of or dependence on alcohol (Ewing, 1984). If 
any of the four questions was positive, it sug-
gested harmful use of alcohol and if all the 4 
questions were positive, it suggested a state of 
dependence. 
Psychiatric morbidity was assessed us-
ing Hospital Anxiety and Depression Scale 
(HADS). This 14-item questionnaire was de-
veloped by Zigmond and Snaith (1983) to de-
termine the presence of anxiety and depression 
among patients with medical conditions. Using 
Likert scoring scale, score range was 0-21 for 
each of the condition. Patients with score of 0-7 
were considered as non- cases, those that scored 
8-10 as borderline and 11 and above as definite 
cases for anxiety or depression. It has been vali-
dated and used in previous studies in Nigeria. 
Fatoye, Mosaku, Komolafe , & Adewuya (2006) 
used HADS in the study of prevalence of anxi-
ety and depression in patients with epilepsy in a 
Nigerian community. Abiodun (1994) reported 
from a Nigerian community that the sensitivity 
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for the anxiety subscale ranged from 85.0% in 
the medical ward and surgical wards to 92.9% 
in the antenatal clinic while sensitivity for the 
depression sub- scale ranged from 89.5% in the 
community sample, while specificity for the 
depression subscale ranged from 86.6% in the 
medical and surgical wards to 91.1% in the ante 
natal and community sample. Misclassification 
rates ranged from 9.9% in the community sam-
ple to 13.2% in the medical and surgical wards. 
Relative operating characteristics (ROC) analy-
ses showed the HADS and the GHQ 12 to be 
quite similar in ability to discriminate between 
cases and non cases. 
reSultS
A total of 167 consecutive adult patients 
who attended VCT clinic in the month of May 
2010 were recruited for the study. All the pa-
tients successfully filled the socio-demograph-
ic section of the questionnaire while one hun-
dred and sixty one of the questionnaires were 
valid for analysis for psychiatric morbidity. 
From Table 1, the age of the patients ranged 
between 20-66 years with a mean age of 37.21 
± 9.38. Female patients constituted 66% while 
majority of them (62%) were of Islamic faith 
and mainly of Hausa ethnic group. Over two-
thirds of the patients were married while 16% 
were widowed. 
About half of the patients used psychoactive 
substances such as tobacco (9; 5.7%), coffee 
(18; 11.3%), kola nuts (43; 27.0%) and solvents 
(2; 1.3%), and 14 (8.8%) reported harmful al-
cohol use. Also, the prevalence of depressive 
disorder was 7.6% while that of anxiety disor-
der was 8.8%. Table 2 showed that substance 
use was frequently found among patients who 
were divorced (62.5%) and who had attained 
tertiary education (63.9%).
From Table 3, anxiety and depression were 
found to be more frequent among the divorced; 
however the difference was not statistically 
significant. Table 4 shows that persons who 
did not have more than primary education ap-
peared to suffer from anxiety and depression 
than those with higher levels of education. 
DiScuSSion
This study explored the prevalence of psy-
chiatric morbidity and substance use among 
patients with HIV infection. In addition, the 
effect of psychosocial variables such as mari-
tal status and educational attainment on the 
prevalence of psychiatric morbidity and sub-
stance use were explored.
This study suggested that the prevalence of 
depressive and anxiety disorder is high. Fac-
tors associated with high prevalence of anxiety 
and depression across marital status and edu-
cation attainment include being divorced and 
education attainment not higher than primary 
education. With regards to substance use, 
prevalence of substance use was high among 
individuals with tertiary education and those 
who were divorced. 
table 1. Demographic characteristics of 
the sample, n (%)
AGE, mean (SD) 34.9 (8.9)
Sex, n (%)
 Male 47 (28.1)
 Female 117 (70.1)
Religion,n (%)
 Islam 106 (63.5)
 Christianity 61 (36.5)
Marital status, n (%)
 Never Married 12 (7.2)
 Married 119 (71.3)
 Separated 2 (1.2)
 Divorced 7 (4.2)
 Widow 27 (16.2)
Education, n (%)
 None 45 (26.9)
 Primary 16 (9.6)
 Secondary 48 (28.7)
 Post Secondary. 53 (31.7) 
Ethnic Group, n (%)
 Hausa 86 (51.5)
 Others 81 (48.5)
PSYCHIATRIC MORBIDITY, SUBSTANCE USE & HIV PATIENTS
14
The prevalence of mood disorder in this 
study was consistent with previous work 
among HIV infected patients in the western 
society. Grant et al (2004) reported the preva-
lence of mood disorders in the US popula-
tion to be 9.21% while that of anxiety disor-
der was 11.08%. However, other subsequent 
studies have reported a higher prevalence. 
For example, Chandra, Ravi, Desai and Sub-
bakrishna (1998) reported the prevalence rate 
of 40% for depression and 36% for anxiety 
among patients who attended tertiary centre 
in India using HADS. Although our study 
was similar to their study with respect to pre-
test and post-test counseling, their patients 
were recruited within 4-6 weeks of revelation 
of HIV status while in our study the period 
of revelation and this investigation varied be-
tween a few weeks to 10 years, hence our pa-
tients may have had enough time to adjust to 
table 2: Relationship between marital status, education and substance use
Yes (%) No (%) χ2 DF p-value
Marital Status
 Single 4 (36.4) 7 (63.6)
 Married 58 (51.3) 55 (48.7)
 Separated 0 (0) 1 (100)
 Divorced 5 (62.5) 3 (37.5)
 Widowed 12 (48) 13 (52.8) 2.440 4 0.656
education
 No formal education 27 (62.8) 16 (37.2)
 Primary 10 (52.6) 9 (47.4)
 Secondary 14 (29.8) 33 (70.2)
 Tertiary 23 (63.9) 13 (36.1)
 Post graduate 5 (41.7) 7 (58.3) 13.650 4 0.008
table 3: Relationship between marital status and psychiatric morbidity 
Variables Anxiety and marital status
Normal (%) Borderline (%) Definite (%) χ2 DF p-value
Not married 7 (63.6) 4 (36.4) 0 (-)
Married 96 (84.2) 5 (4.4) 11 (9.6)
Separated 1 (100) 0 (-) 0 (-)
Divorced 7 (87.5) 0 (-) 1 (12.5)
Widow 22 (88.0) 1 (4.0) 2 (8.0) 18.94 8 0.01
Depression and marital status
Not married 7 (63.6) 3 (27.3) 1 (9.6)
Married 95 (84.8) 7 (6.2) 9 (8.0)
Separated 0 (-) 1 (100) 0 (-)
Divorced 7 (87.5) 0 (-) 1(12.5)
Widow 20 (80) 4 (16) 1 (4.0) 17.44 8 0.03
YUNUSA ET AL.
15
the illness when compared with their patients. 
Lower prevalence of substance use disorders 
of 9.35% in a similar cohort has been reported 
by Grant et al. (2004). However another study 
by Bing et al (2001) reported that the preva-
lence of substance use among HIV infected 
patients was 40%. This difference may not be 
unrelated to lower use of alcohol among the 
predominantly Muslim community where the 
study was carried out. 
With regards to educational attainment and 
substance use, our findings were in contrast 
to those of Gfroerer, Greenblatt and Wright 
(1997) who reported that low educational at-
tainment were associated with high prevalence 
of substance use. This difference may relate 
to methodological differences. While these 
studies reported mainly on illicit drugs, our 
subjects reported mainly on licit substances 
which are culturally acceptable. For example, 
kolanut is frequently used in most parts of Ni-
geria under several social circumstances in-
cluding marriage, burial and baby christening 
among others. In addition, tertiary education 
is frequently associated with prolonged hours 
of academic activities and some of these sub-
stances are used to keep the students awake. 
Hence a student may subsequently form the 
habit of using the drug.
We acknowledge several limitations to this 
study. The present study describes psychiatric 
morbidity among a selected group of patients 
referred to a tertiary care centre. It is not pos-
sible to generalize these findings to the entire 
population of the catchment area of the study, 
especially those without access to counseling 
services. Also, the psychological instrument we 
used could not categorize the patients into ICD 
or DSM classification hence may be difficult to 
describe the severity of the psychiatric morbidi-
ty. The absence of control group was also a limi-
tation as adequate comparison was not possible.
In conclusion, this study suggests the need 
for routine assessment of psychological dis-
tress by simple screening methods. Psycholog-
ical distress appeared to be highly correlated 
with being single. Hence, adequate attention 
to the social circumstance of the patients is 
necessary.
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table 4: Relationship between education and psychiatric morbidity
Anxiety and education
Normal (%) Borderline (%) Definite (%) χ2 DF p-value
No formal education 37 (84.1) 3 (6.8) 3 (6.8)
Primary 16 (84.2) 0 (-) 3 (15.8)
secondary 42 (89.4) 2 (4.3) 2 (4.3)
Tertiary 30 (83.3) 2 (5.6) 4 (11.1)
Post graduate 8 (66.7) 3 (25) 1 (8.3) 11.33 8 0.18
Depression and education
No formal education 35 (81.4) 5 (11.6) 3 (7.0)
Primary 13 (68.4) 3 (15.8) 3 (15.8)
secondary 41 (87.2) 2 (4.3) 3 (6.4)
Tertiary 29 (82.9) 4 (11.4) 2 (5.7)
Post graduate 10 (83.3) 1 (8.3) 1 (8.3) 4.996 8 0.758
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